01 1Dipharma
01 1CILOSTAZOL
01 1Italy
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-02-27
Pay. Date : 2019-02-25
DMF Number : 17050
Submission : 2003-12-22
Status : Active
Type : II
20
Dipharma Francis Srl, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CILOSTAZOL, with a corresponding US DMF Number 17050.
Remarkably, this DMF maintains an Active status since its submission on December 22, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 27, 2019, and payment made on February 25, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
LOOKING FOR A SUPPLIER?